Surgery Doctors in Lufkin, TX Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Waldo Gonzalez, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 302 Medical Park Dr, Suite 101, Lufkin, TX 75904 Phone: 936-634-8216    Fax: 936-634-8723

Darry G Meyer, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 302 Medical Park Dr, Suite 101, Lufkin, TX 75904 Phone: 936-634-8216    Fax: 936-634-8723

Trung Quang Ho, M.D. Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 1105 W Frank Ave Ste 280, Lufkin, TX 75904 Phone: 936-639-7895    Fax: 936-639-8971

Dr. Mel Cole, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 W Frank Ave Ste 301, Lufkin, TX 75904 Phone: 936-639-1740

Jeffrey Scott Hamaker, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 302 Medical Park Dr Ste 101, Lufkin, TX 75904 Phone: 832-922-3589

Ashley Mcelroy, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 302 Medical Park Dr Ste 101, Lufkin, TX 75904 Phone: 936-209-3080    Fax: 936-634-8723

News Archive

Hologic releases C-View synthesized 2D image reconstruction algorithm

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the commercial release of its C-View synthesized 2D image reconstruction algorithm that eliminates the need for a conventional 2D mammogram as a component of a tomosynthesis (3D mammography) breast cancer screening exam.

‘Design thinking' could help address public health challenges

Public health challenges such as poor diet, smoking and binge drinking are just a few lifestyle issues that could be addressed with some ‘design thinking' according to Design Council and the Local Government Association.

Unmanned drones could be economical to deliver vaccines quickly in developing countries

Using unmanned drones to deliver vaccines in low- and middle-income countries may save money and improve vaccination rates, new research led by the Johns Hopkins Bloomberg School of Public Health and the Pittsburgh Supercomputing Center suggests.

Bionovo prices public offering of common stock at $1.30 per share

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the pricing of its previously announced underwritten public offering, to sell up to 30,031,200 units at a price per unit of $1.00 for aggregate gross proceeds of approximately $30 million.

Read more Medical News

› Verified 7 days ago